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ABSTRACT
The epigenetic modification of 5-hydroxymethylcy-
tosine (5hmC) is receiving great attention due to its
potential role in DNA methylation reprogramming
and as a cell state identifier. Given this interest, it
is important to identify reliable and cost-effective
methods for the enrichment of 5hmC marked DNA
for downstream analysis. We tested three commonly
used affinity-based enrichment techniques; (i)
antibody, (ii) chemical capture and (iii) protein
affinity enrichment and assessed their ability to ac-
curately and reproducibly report 5hmC profiles in
mouse tissues containing high (brain) and lower
(liver) levels of 5hmC. The protein-affinity technique
is a poor reporter of 5hmC profiles, delivering 5hmC
patterns that are incompatible with other methods.
Both antibody and chemical capture-based tech-
niques generate highly similar genome-wide pat-
terns for 5hmC, which are independently validated
by standard quantitative PCR (qPCR) and glucosyl-
sensitive restriction enzyme digestion (gRES-qPCR).
Both antibody and chemical capture generated
profiles reproducibly link to unique chromatin modi-
fication profiles associated with 5hmC. However,
there appears to be a slight bias of the antibody to
bind to regions of DNA rich in simple repeats.
Ultimately, the increased specificity observed with
chemical capture-based approaches makes this an
attractive method for the analysis of locus-specific
or genome-wide patterns of 5hmC.
INTRODUCTION
Direct chemical modiﬁcation of cytosine bases found in
the dinucleotide sequence CpG is a common method of
epigenetic regulation in the mammalian genome (1). The
most common form of this modiﬁcation is the addition of
a methyl group to the carbon 5 position on the pyrimidine
ring by a family of DNA methlytransferase enzymes
(Dnmt1, Dnmt3a and Dnmt3b) to form 5-methylcytosine
(5mC). Methylation events are thought to be of critical
importance in the silencing of the many repetitive
elements found in mammalian genomes as well as
having proposed roles in the regulation of imprinting,
X-inactivation, constraining polycomb repressor complex
(PRC2) targeting of H3K27me3 and general promoter
activity (2–4). Recently, there has been renewed interest
in the ﬁeld of DNA methylation due to the identiﬁcation
of a novel set of modiﬁed cytosine bases, all of which
are found over CpG dinucleotides albeit at far lower
abundances than the 5mC modiﬁcation (5). The most
prevalent of these modiﬁed bases, corresponding to
<1% of cytosine bases in mouse and human tissues, is
that of 5-hydroxymethylcytosine (5hmC). Although ini-
tially discovered more than 60 years ago, this modiﬁcation
has only recently been comprehensively studied in mam-
malian genomes (for a review see (6)) and has since been
proposed to be part of a demethylation pathway due to
the ﬁnding that it is formed through oxidation of a methyl
group into a hydroxymethyl group at cytosine bases by
the Tet-eleven-translocation (TET) family of Fe(II) and
a-KG-dependent dioxygenases (Tet1, Tet2 and Tet3)
(7–10). These same enzymes have also been shown to
further convert the 5hmC-modiﬁed cytosines to the de-
rivatives 5-formylcytosine (5fC) and/or 5-carboxylcytosine
(5caC), which have been proposed to ultimately result in
base excision repair (BER) and replacement with a non-
modiﬁed cytosine base (11–14). Disruption of the TET
proteins has been reported to result in globally reduced
5hmC levels, a phenomenon also seen during carcinogen-
esis (15). In addition, knockdown of TET1 in embryonic
stem cells (ESCs) leads to an increase in 5mC over tran-
scriptional start sites (TSSs) alongside loss of 5hmC at
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speciﬁc promoters and within gene bodies of TET1 target
genes (16–18). Knockdown of Tet2 in hematopoietic pro-
genitor cells was found to perturb the normal gene expres-
sion pathways involved in differentiation resulting in a
block of myeloid differentiation (19,20) while activation
of Tet2 target genes in pre-B cells was also seen to accom-
pany changes in the promoter speciﬁc patterns of the
5hmC modiﬁcation (21). Work in Xenopus suggests that
the Tet3 CXXC domain is required for its targeting to the
promoters of genes that are critical for eye and neural
development (22). Deletion of the CXXC DNA binding
domain from xlTet3 abolishes its ability to occupy target
gene promoters, thereby preventing developmental
demethylation that is normally associated with their acti-
vation. Recently, an ancestral CXXC protein, IDAX,
which became separated from TET2 following chromo-
somal rearrangement, has been shown to have a role in
both recruiting TET2 to target genes and regulating its
protein stability, ultimately impacting on its dioxygenase
activity (23).
The ﬁeld of 5hmC research has advanced rapidly over
the past 3 years as the number and accuracy of techniques
with which to enrich for 5hmC-containing DNA has
increased, especially when combined with the affordability
of tilling arrays (24–26) and access of next generational
sequencing (NGS) technologies (27).Many of the initial
genome-wide studies have focused on the enrichment of
5hmC-containing DNA fragments through antibody pre-
cipitation-based methods (hmeDIP), which were similar to
the already well-established methyl-DNA immunopre-
cipitation (MeDIP) protocols (17,28,29) (Figure 1a).
Although the majority of these studies were carried out
on mouse embryonic stem cells (mESCs), which contain
relatively low levels of 5hmC, they successfully mapped
the genome-wide distribution of the modiﬁcation, reveal-
ing that 5hmC is typically depleted over the TSSs and
enriched in the bodies of highly expressed genes. There
was also some evidence to suggest that 5hmC was
enriched at repetitive elements, particularly those of the
Line1 family (28). However, subsequent studies high-
lighted potential bias of anti-5hmC antibodies for
recognizing modiﬁcation dense regions (30) as well as
showing some bias towards CA repeat sequences (31).
Around the same time, several groups also developed
afﬁnity-based methods to enrich for 5hmC marked DNA
(32–35). The T4 bacteriophage enzyme b-glucosyltrans-
ferase (bGT) is central in many of these techniques due
to its ability to speciﬁcally modify 5-hydroxymethyl
modiﬁed cytosine bases through glucosylation, yielding
the base, glucosyl-5hmC. By including a chemically
altered glucose group within this reaction so that subse-
quently modiﬁed glycosyl-5hmC bases can bind biotin, a
technique was developed whereby streptavidin puriﬁca-
tion would result in extremely efﬁcient puriﬁcation of
DNA fragments (termed hydroxymethyl selective
chemical labelling or hMeSeal) (32). Unlike hmeDIP,
hMeSeal enrichment can be carried out on very small
amounts of material (<100 ng starting sample) and does
not appear to suffer from the previously reported CpG
bias issues described for hmeDIP, as such providing a
method suitable for the analysis for 5hmC levels in
regions of low CpG density. A similar approach to the
hMeSeal technique was also developed whereby bGT
glucosylated 5hmC DNA fragments are subjected to an
additional reaction with sodium periodate in order to
allow the incorporation of two biotin groups
(glucosylation, periodate oxidation, biotinylation or
GLIB) (30); however, this extra enzymatic step has been
known to introduce DNA damage as well as introduce
some background effects (5). A third approach based on
the afﬁnity of the trypanosome J binding protein 1 (JBP-1)
towards glucosylated 5hmC has also been reported (34);
however, only one subsequent study has utilized this tech-
nology, reporting little to no enrichment of 5hmC in
the zebraﬁsh during embryogenesis (36). In addition to
these bGT-based protocols, 5hmC enrichment has also
been carried out through antibody-based puriﬁcation of
modiﬁed forms of 5hmC (anti-cytosine 5-methylene-
sulphonate; CMS) (30) as well as techniques allowing
potential single base resolution sequencing through
either oxidative bisulphite sequencing (oxBS-seq) or TET
assisted bisulphite sequencing (TAB-seq) (33,35).
Although the single base resolution strategies have the
potential to yield superior levels of information regarding
genome-wide 5hmC distribution, the relative sequencing
costs required to provide sufﬁcient depth to cover the
entire genome and accurately map the low amounts of
5hmC makes such techniques less cost effective than
many of the alternative afﬁnity-based methods presently
available.
With this in mind, we set out to comprehensively test
three affordable and widely used afﬁnity-based techniques
for 5hmC enrichment (antibody (hmeDIP); chemical
capture (hMeSeal) and afﬁnity puriﬁcation (JBP-1 puriﬁ-
cation)) on two different mouse tissues, which vary in their
global levels of the 5hmC modiﬁcation (whole
brain=high levels at 0.7% of dG, liver= intermediate/
low levels at 0.07% of dG) (15,37). In contrast, 5mC levels
(4.5% of dG) are comparable between the two tissues (37).
We have compared the distributions of the enriched frag-
ments on high-density 2.1 million probe tiled microarrays
(which due to the total number and density of probes
mirror published genome-wide sequencing datasets
closely; see Supplementary Figure S1), allowing us to
compare the 5hmc patterns generated by the various af-
ﬁnity-based enrichment techniques in a cost-effective
manner without any loss of data integrity. Following
these microarrays, we carry out independent validation
of our results by both standard quantitative PCR
(qPCR) as well as by a hydroxymethylation sensitive re-
striction enzyme PCR-based strategy (gRES-qPCR) which
allows us to quantify absolute levels of DNA modiﬁcation
at single CpG dinucleotides. This technique has been pre-
viously used to successfully validate both HmeDIP based
(15,25) and oxBS-seq derived (35) 5hmC datasets.
Additionally, we also compare our data to already pub-
lished 5hmC microarray-based datasets (25,26). From our
analysis, we ﬁnd that the JBP-1 afﬁnity-based technique
does not sufﬁciently enrich for 5hmC-containing DNA to
allow for accurate mapping of the modiﬁcation in the
genomes of tissues analysed. In contrast, both hmeDIP
and hMeSeal generated similar patterns of distribution
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Figure 1. Genome-wide 5hmC patterns in mouse whole brain and liver DNA following enrichment by either antibody, chemical capture or protein
afﬁnity-based methods. (a) An overview of the three commercially available techniques for 5hmC enrichment. In our study, following enrichment we
carried out whole genome ampliﬁcation and dye labelling for micro-array hybridization. (b) qPCR validation of the relative enrichment efﬁciencies
over candidate loci previously identiﬁed as being either enriched or depleted in 5hmC in the mouse liver (26). Following normalization to the negative
region at the Gapdh promoter, all three techniques report similar ﬁndings; however, the JBP-1-based afﬁnity technique gives very low enrichment
values compared to the hmeDIP and hMeSeal methods. Red dotted line denotes no enrichment over Gapdh. (c) Pearson correlation analysis and
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(continued)
on a probe by probe as well as the genic level, although
higher levels of background noise were observed with
hmeDIP. In addition, both of these enrichment techniques
result in similar associations with chromatin modiﬁcations
typically found at enhancers and gene bodies, while the
JBP-1 enriched material showed less obvious relation-
ships. Focusing on the hmeDIP and hMeSeal techniques,
we deﬁne a small number of regions which display signiﬁ-
cant variance between these two datasets revealing that
the antibody is not only biased towards CA repeats and
Line1 elements as previously reported (28,31), but also
recognizes a full spectrum of simple repeats. Finally,
these regions of variance appear to be most pronounced
across imprinted regions in our array set such as the H19/
Igfr2 and the Tsix/Xist loci, which are correspondingly
enriched for simple repeats. As such, although both tech-
niques accurately report the hydroxymethylome patterns
in mouse tissues, we conclude that the hMeSeal chemical
capture-based technique is currently the optimal afﬁnity-
based enrichment technique that is widely available for
laboratories interested in the study of 5hmC.
MATERIALS AND METHODS
Mouse strains
Adult male C57BL/6 mice were sacriﬁced and livers taken
for subsequent DNA extraction. DNA was extracted from
small pieces of liver following digestion with proteinase K
prior to phenol chloroform. During analysis, datasets were
also compared to B6CH3HF1 hybrid mice (GSE40540).
Puriﬁcation of 5hmC and 5mC enriched DNA fragments
Prior to puriﬁcation, genomic DNA was extracted from
frozen (80C), ground-up livers and fragmented to an
average of 500 bp for hmeDIP protocols and 300 bp for
JBP-1 and hMeSeal protocols (Bioruptor, Diagenode).
For an overview of the three techniques see Figure 1a.
Antibody (hmeDIP)
Genomic DNA was sonicated (Bioruptor, Diagenode) to
produce DNA fragments ranging in size from 200 to
1000 bp, with a mean fragment size of around 300 bp. A
total of 4 mg of fragmented DNA was immunoprecipitated
for 3 h at 4C with 2.5ml of a rabbit polyclonal antibody
against 5hmC (Active motif, cat#39769) in a ﬁnal volume
of 500 ml IP buffer (10mM sodium phosphate (pH 7.0),
140mM NaCl, 0.05% Triton X-100). This mixture was
incubated with 60 ml of magnetic M-280 protein G
Dynabeads (Invitrogen #100-03D) for 2 h prior to
washing all unbound fragments three times with 1ml IP
buffer. Washed beads were then incubated with pK for 2 h
at 50C. Immunoprecipitated DNA fragments were then
puriﬁed by passing through DNA puriﬁcation columns
(Quiagen) and eluting into Tris-EDTA buffer pH 8.0 (TE).
Chemical capture (hMeSeal)
Chemical capture (hMeSeal) methods were developed in
the He lab at the Univeristy of Chicago (32) and marketed
under the name Hydroxymethyl Collector Kit by Active
Motif (cat# 55013). Following sonication of the DNA to
a mean size of 300 bp, 1 mg of fragmented DNA was
glucosylated through incubation with modiﬁed dUTP
containing an azide glucose group with 20 U bGT
enzyme for 1 h at 37C. Following glucosylation, the
modiﬁed glucose group was then biotinylated through
incorporation of biotin conjugation solution for 1 h
further at 37C. Fragments of DNA containing modiﬁed
biotin-azide-glucose-5hmC were then puriﬁed through
binding to magnetic streptavidin beads following ﬁve
washes with a wash buffer and a ﬁnal wash in elution
buffer for 30 min at room temperature. Puriﬁed DNA
was then passed through DNA puriﬁcation columns and
eluted in elution buffer prior to qPCR and microarray
hybridization. All chemicals described were supplied with
Hydroxymethyl Collector Kit by Active Motif (cat#
55013). Please refer to manufacturers’ protocol for more
information. Following the work carried out in this
study, we found some long-term stability issues with
latter batches of the active motif bGT enzyme. As such,
we suggest substituting 20 U per reaction of the active
motif T4-phage bGT enzyme for 30 U/rxn of the T4-
phage bGT enzyme supplied from New England Biolabs
(NEB, Cat# M0357L).
JBP-1 protein afﬁnity
JBP-1 afﬁnity pull-down technology was developed in the
Klungland Lab at the Oslo University Hospital
Rikshospitalet, Norway, and is marketed by Zymo
research under the name Quest 5hmC DNA enrichment
clustering among the microarray datasets. Biological replicates cluster closely while tissues clustered independently conﬁrming the tissue-speciﬁc
nature of 5hmC patterns. JBP-1 afﬁnity puriﬁed 5hmC datasets correlate poorly with the hmeDIP and hMeSeal sets (d) Autocorrelation analysis of
5hmC patterns determined by hmeDIP, hMeSeal and JBP-1-binding in a single mouse brain sample. Autocorrelation was determined to a distance of
40 probes (10 kb). A ‘random’ sample for comparison was generated by randomization of the hMeSeal data. Filled circles represent relative probe
position. (e) Example of microarray datasets showing tissue speciﬁcity and biological replicate reproducibility between each technique over the liver
speciﬁc gene Cyp2b10. Data are plotted on log2 scales from 3 to +3. Biological replicates are numbered 1 and 2, respectively. Gene structure is
shown below by blue bars. Boxed regions are expanded upon on the right to display regions independently validated by gRES-qPCR. Plots represent
the percentage of each modiﬁcation at a single CpG in the sequence CCGG following normalization (purple; 5hmC, red; 5mC, green; C). Error bars
display the standard error of the biological replicates. (f) Percentage plots of the distributions of 5hmC enriched regions following hmeDIP, hMeSeal
and JBP-1 5hmC puriﬁcation. Peak probes of 5hmC enrichment were deﬁned (see ‘Materials and Methods’ section) and then mapped to one of ﬁve
unique genomic loci (promoter cores, proximal and distal regions as well as intra- and inter-genic regions; box on right). Red dotted lines highlight
changes in the distributions between techniques. Boxed region is expanded upon to reveal technique dependant differences over promoter-core,
-proximal and -distal peaks. (g) The number and distribution of 5hmC peak probes generated for the three techniques are low over CpG islands
(CGI) and largely non-promoter associated. Pie charts representative of the dataset size reveal low numbers of CGI related 5hmC peak probes
following hmeDIP or hMeSeal in the brain (i) and the liver (ii). The total number of peaks mapping to CGIs are shown in square brackets while
round brackets denote the total per cent of probes on the arrays which overlapped with CGI enriched peaks. Pink=peak probes mapping to
promoter CGI regions, brown=peak probes mapping to orphan CGI (non-promoter) regions.
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kit (cat#D5421). In short, Genomic DNA was sonicated
(Bioruptor, Diagenode) to produce DNA fragments
ranging in size from 200 to 1000 bp, with a mean
fragment size of around 300 bp. Following the manufac-
turers protocols, 1 mg of fragmented DNA was then
glucosylated through incubation with glucose-modiﬁed
dUTP and 4 U bGT enzyme for 1 h at 37C. Following
glucosylation, the DNA was incubated with magnetic JBP
capture beads containing the JBP-1 protein for 2 h at
room temperature. Beads were then washed in wash
buffer before eluting with the provided elution buffer.
All chemicals described were supplied with name Quest
5hmC DNA enrichment kit supplied by Zymo research
(cat#D5421). Please refer to manufacturers’ protocol for
more information.
Microarray hybridization
Following puriﬁcation, material for validation was set
aside and the remaining samples prepared for microarray
analysis by whole genome ampliﬁcation using WGA2:
GenomePlex Complete Whole Genome Kit (Sigma).
Ampliﬁed material was then labelled and hybridized to
2.1M whole genome mouse tiling array set 2 of 4
(Roche Nimblegen), which covers a proportion of
chromosomes 4 and 9 and all of chromosomes 5,6,7 and 8.
Processing of Nimblegen tiled microarrays
Nimblegen 2.1M deluxe mouse tiled arrays (mm9 build)
contain 2 171 066 unique probes of 50–70 bp in length
spanning 6777 unique genes. Signals for each probe of
the 5hmC-enriched samples (Cy5 labelled) were
compared to input samples (Cy3 labelled) to generate
log2 (IP/Input) scores (fold changes). These log2 scores
were then normalized ﬁrst by Loess normalization and
then by scale normalization using the Limma package in
R/Bioconductor (38). For all samples, each probe was
then mapped to one of ﬁve regions of the genome based
on Refseq gene annotations: promoter core=TSS
+100 bp to 100 bp, promoter proximal=TSS+1kb to
+100 bp, promoter distal=TSS +2kb to +1kb, intra-
genic=gene body or inter-genic=not associated with
an aforementioned region (Figure 1e). Due to the highly
reproducible nature of the patterns, average probe values
were calculated for biological replicates for both brain and
liver samples.
Bioinformatic analysis
Genome-wide analysis of the datasets was carried out
using R/Bioconductor or the Wellcome trust Centre for
Cell Biology Galaxy server. Peaks representing probes
that were enriched in 5hmC were deﬁned in a similar
fashion to those outlined in (26), but with the criteria
changed so that at least three out of four probes had to
reach the 95th percentile threshold. Peaks were mapped to
one of ﬁve unique regions of the genome through direct
overlap. Non-uniquely mapping peak probes (i.e.
mapping to a promoter which overlaps a genic region of
a second gene) were excluded from the analysis. Peak
probes mapping to CpG islands were mapped in a
similar way.
Average levels of 5hmC over genes were calculated by
taking the average of all probes mapping to a particular
gene (log2 scores) and then dividing by the length of the
gene in base pair.
To calculate the probe differences in the 5hmC patterns
generated between the hmeDIP and hMeSeal datasets,
average 5hmC values were ﬁrst calculated for biological
replicates and the hmeDIP values subtracted from the
hMeSeal log2 scores (frequently referred to as enrichment
bias in the antibody relative to the chemical capture or
5hmC hmeDIP versus hMeSeal). Probes seen to differ
greater than 1.5-fold over a window of at least three
probes were selected for further analysis (Figure 3a).
Clustering of samples based on their DNA modiﬁcation
samples was calculated from 500 000 random probes
(24.3% total unique probes on array). Dendrogram plots
were carried out using R and distances calculated through
both Euclidian and Ward methods. Scatter plots of
500,000 random probes or total genic 5hmC levels were
drawn using the plot and smoothscatter functions. Kernel
density plots were plotted using the density function.
Boxplots were drawn using the function boxplot.
CpG calculations were carried out on the Wellcome
trust Centre for Cell Biology Galaxy server using the
‘CpG calculation’ tool. Average patterns of 5hmC across
genes were carried out using the tool ‘sliding window over
length normalised regions of interest’. In short, this
function takes a set of genomic coordinates (gene
start+25% upstream and stop+25% downstream) and
calculates the patterns of 5hmC from the supplied
genome-wide data ﬁle based on the % length of each
gene. Average signals were drawn for biological replicates.
Bioinformatic analysis of ENCODE/LICR histone
modiﬁcation datasets
Genome-wide ChIP-seq data perfomed by the Ren lan,
UCSC as part of the ENCODE project, was downloaded
from the UCSC genome browser database in accordance
with published guidelines (39). All datasets were analysed
following the arbitrary 9 month ‘moratorium’ on the pub-
lication that expired on December 2012. Following
antibody enrichment, samples were sequenced on
Illumina Genome Analyzer II, Genome Analyzer IIx
and HiSeq 2000 platforms for 36 cycles. Image analysis,
base calling and alignment to the mouse genome version
NCBI37/mm9 were performed using Illumina’s RTA and
Genome Analyzer Pipeline software. Alignment to the
mouse genome was performed using ELAND or Bowtie
with a seed length of 25 and allowing up to two
mismatches. Only the sequences that mapped to one
location were used for further analysis. Patterns of
histone modiﬁcations were subsequently generated and
peaks of enrichment were calculated, both of which are
freely available on the USCS browser under the tab ‘LICR
Histone Mods’.
For our analysis, we compared the peaks of 5hmC en-
richment to the reported peaks of histone modiﬁcation.
Data was ﬁrst restricted to the regions present on the
mouse 2.1M high-density tiled microarray 2 of 4 (Roche
Nimblegen). Following this, regions of the genome which
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contained a peak of only one histone modiﬁcation (i.e.
only H3K4me3 and not also H3K27me3 for example’’)
were deﬁned by subtracting the coordinates of the peak
sets for each mark. Plots of overlap were generated as a
proportion of the total number of these unique histone
peaks which also overlap by at least 1 bp with a peak of
5hmC.
Sliding window analysis was carried out using the
same procedure outlined above to calculate average
5hmC proﬁles across gene bodies (through the use of the
Wellcome trust Centre for Cell Biology Galaxy ser-
ver ‘sliding window over length normalised regions of
interest’ tool). Midpoints of histone peaks were
calculated and regions expanded out + and 5 kb.
5hmC patterns from our arrays were tested across these
10 kb windows.
Deﬁnition of simple tandem repeats and repeat elements
List of simple tandem repeats and repeat elements
were generated by using the tandem repeat ﬁnder
program supplied by the Boston University and the
repeat masker program developed by the Institute for
systems biology, Seattle. Both sets of data were available
through the UCSC genome browser at http://genome.
ucsc.edu.
Glucosylation-mediated restriction enzyme sensitive qPCR
(gRES-qPCR)
The EpiMark kit (NEB) was used to quantify relative
levels of 5hmC and 5mC at select loci in mouse brain
and liver DNA. All data were scaled at each locus so
that the total per cent of marks=100 and as such only
relative and not absolute levels of each mark to be
calculated. For the full protocol see the manufacturer’s
instructions. Typically, 10 mg of genomic DNA was
taken and half treated with T4-phage bGT for 12–16 h
at 37C. Both the bGT treated and untreated samples
were then divided into three PCR tubes and digested
with either MspI, HpaII or left uncut for a further
12–16 h at 37C. Samples were proteinase K treated for
10 min at 40C prior to dilution to 100 ml ﬁnal volume in
H20 and heating to 95
C for 5 min. qPCR was carried out
on 5 ml (0.8 mg DNA) of each sample on a Roche
LightCycler 480 PCR machine. Relative enrichments
of the modiﬁcations were then calculated following
formulae provided by NEB.
Data access
Data available on the Gene Expression Omnibus (GEO)
under accession number GSE51577. Published 5hmC
and 5mC microarray datasets studied in this work can
be found in GEO under the super-series GSE40540.
HmeDIP-seq datasets generated by the Shen lab can be
found in GEO under the super-series GSE42250. ChIP-seq
datasets generated by the Ren lab as part of the ENCODE
project are accessible via the UCSC genome browser.
RESULTS
High-density analysis of liver 5-hydroxymethylome
patterns enriched by antibody, chemical capture and
afﬁnity-based methods
The number of potential tools for the enrichment of DNA
modiﬁcations is increasing, with recent studies mapping
even the low abundant 5fC and 5Cac modiﬁcations in
mouse DNA (13,14). Previous work has been carried
out to evaluate both afﬁnity and antibody-based
methods of 5mC enrichment reporting discrete technique
dependant differences (40). We set out to comparatively
test the 5hmC enrichment properties of the widely used
immunoprecipitation-based puriﬁcation method
(hmeDIP), with respect to two recently reported antibody
independent methods, namely selective chemical labelling
(hMeSeal) (32) and JBP-1 afﬁnity puriﬁcation (34). An
overview of the techniques and chemistry involved in
these three methods is outlined in Figure 1a. In brief,
hmeDIP is based on immunoprecipitation of DNA frag-
ments with antibodies highly speciﬁc for the 5hmC modi-
ﬁcation. In contrast, both the hMeSeal chemical capture
and JBP-1 afﬁnity capture techniques rely on several steps
of chemical modiﬁcation prior to puriﬁcation, primarily
involving the complete glucosylation of 5hmC modiﬁed
cytosines using the T4 bacteriophage enzyme bGT. In
the case of hMeSeal, the newly glucosylated cytosines
are then biotinylated permitting high-afﬁnity streptavidin
puriﬁcation. The JBP-based puriﬁcation techniques rely
on the afﬁnity of the JBP-1 protein for glucosylated
DNA, which in turn is puriﬁed through the binding to
magnetic beads.
We initially tested the relative enrichment properties of
these three techniques over a cohort of loci which we pre-
viously identiﬁed to be either enriched or depleted in the
5hmC modiﬁcation in the mouse liver (26) by quantitative
PCR (qPCR) (Figure 1b). From this analysis, it was
apparent that both the hmeDIP and hMeSeal approaches
were speciﬁcally enriching for 5hmC marked regions of
DNA, while the results of the JBP-1 afﬁnity puriﬁcations,
although showing a similar trend, were weaker. This is
likely due to the fact that the amount of DNA recovered
following the use of this approach was far lower than the
hmeDIP and hMeSeal techniques. For example, qPCRs
carried out on hmeDIP and hMeSeal enriched material
typically reached their cycle threshold of ampliﬁcation
(Ct) between 30 and 40 cycles while JBP puriﬁed DNA
fragments routinely took >50 cycles to reach the cycle
threshold (Ct) indicating that the amount of DNA
present is extremely low (Supplementary Figure S2a). To
ensure this was not due to an isolated issue with the JBP-1
protein preparation, we repeated the enrichment using a
second batch of JBP-1 and achieved similarly high Ct
values (Supplementary Figure S2). As such JBP-1-based
techniques of purifying 5hmC enriched DNA resulted in
low levels of enrichment relative to input DNA compared
to hMeSeal and hmeDIP (Supplementary Figure S2b).
The increased variability introduced by high cycle thresh-
olds makes it difﬁcult to reliably quantify levels of the
modiﬁcation using JBP-1. Interestingly, Ct values were
also higher for the hMeSeal enriched DNA compared to
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those obtained with hmeDIP (Supplementary Figure S2a)
highlighting that although relative enrichment values
across loci are high for this approach, the absolute level
of 5hmC enriched DNA returned is lower. Signiﬁcantly,
relative levels of 5hmC enrichment were similar for all
three approaches irrespective of the absolute enrichment
levels observed (Figure 1b).
Following this candidate-driven approach, we wished to
test the ability for these techniques to enrich and therefore
report on the patterns of 5hmC modiﬁcation across a large
proportion of the mouse genome. To do so, we carried out
puriﬁcation of 5hmC marked DNA in both mouse brain
and liver tissues (n=2) using the hmeDIP and hMeSeal
techniques prior to hybridization on high-density tiled
microarrays covering 25% of the mouse genome
(chromosomes 4–9). Due to the low levels of 5hmC en-
richment of 5hmC using the JBP-1 afﬁnity-based method
observed through qPCR (Figure 1b and Supplementary
Figure S2), JBP-1 proﬁling was performed on a single
brain sample as this tissue would contain the high levels
of 5hmC required by JBP-1. In agreement with the qPCR
results described earlier, hierarchical clustering of the
microarray data reveals that the 5hmC patterns generated
by the JBP-1 afﬁnity approach clusters completely inde-
pendently and is lowly correlated (Pearson’s correlation
value <0.25) from those puriﬁed by hmeDIP or
hMeSeal (Figure 1c). In contrast, the hmeDIP and
hMeSeal datasets were highly correlated (mean
Pearson’s correlation values of >0.79 for brain and 0.71
for liver datasets; Figure 1c), and clustered for each tissue.
Furthermore, low levels of individual variation was noted
between biological replicates of each technique (for
example, Pearson’s correlation values of 0.87 between
the brain 1 and brain 2 HmeDIP sets; Figure 1c) which
agrees with results of recent work highlighting the repro-
ducible nature of the 5-hydroxymethylome between indi-
viduals (25).
To gain an overview of the signal-to-noise ratio and
periodicity of the data, we performed autocorrelation
analysis of the tiling microarray data for hme-DIP,
hMeSeal and JBP-1 binding in a single brain sample
(Figure 1d). For comparison, a randomized data set was
generated from the hMeSeal data. Probe values for both
the hMeSeal and hme-DIP data were strongly correlated
with that of neighbouring probes to 2 kb, and show
continued association across the 10-kb region analysed.
Interestingly, although the pattern of autocorrelation
was highly similar for both hmeDIP and hMeSeal, the
latter showed consistently higher autocorrelation values
reﬂecting a higher signal-to-noise ratio to that of
hmeDIP. Relative to the hmeDIP and hMeSeal data, the
JBP-1 data showed vastly reduced correlation between
probes at all distances assayed, and closely resembled
the autocorrelation proﬁle obtained with random data
(which was also apparent from the microarray proﬁles;
Supplementary Figure S3), reﬂecting a markedly lower
signal-to-noise ratio.
It has been widely reported that 5hmC modiﬁed DNA is
typically found in the bodies of actively transcribing genes
(17,18,26,28,29,32,41) and enhancer elements (13,41,42)
and that overall 5hmC patterns are highly tissue speciﬁc
(15). Accordingly, hierarchical clustering of the high-
density tiled microarray datasets reveals that the 5hmC
patterns vary more between tissues than between tech-
niques of enrichment (Figure 1c), reinforcing the overall
similarity of the 5hmC datasets generated by the hmeDIP
and hMeSeal (but not JBP-1 afﬁnity) techniques.
Subsequent visualization of the relative 5hmC patterns
across tissue-speciﬁc genes such as the liver-speciﬁc gene
Cyp2b10 reveals the ability of the hmeDIP and HmeSeal
techniques to reﬂect the tissue-speciﬁc 5hmC patterns
(Figure 1e). Furthermore, both techniques display highly
reproducible patterns of 5hmC enrichment between indi-
viduals as seen by the similar proﬁles in the biological
replicates of each technique (Figure 1e). To independently
validate these ﬁndings, we carried out glucosylation-
mediated restriction enzyme sensitive qPCR (‘gRES-
qPCR’, see ‘Materials and Methods’ section) over
regions containing a single MspI cut site. In short, this is
based on the relative ability for the restriction enzymes
HpaII and MspI to cut 5mC, 5hmC and non-modiﬁed
CpG dinucleotides in the sequence CCGG. When
glucosylated, the MspI enzyme can no longer recognize
the modiﬁed CpG and the relative ability to subsequently
amplify by qPCR is representative of the cut frequency
and hence modiﬁcation status (see ‘Materials and
Methods’ section). The gRES-qPCRs carried out over
loci at the Cyp2b10 gene strongly validate both
the hmeDIP and hMeSeal techniques while once more
highlighting the non-speciﬁc nature of JBP-1 puriﬁcation
techniques (Figure 1e and Supplementary Figure S3).
To fully characterize the 5hmC patterns generated by
each technique, we generated datasets of probes residing
in regions enriched in 5hmC (peak probes: see ‘Materials
and Methods’ section). This analysis reveals that globally
more peak probes are deﬁned in the hMeSeal generated
libraries (e.g. 161 142 peaks in the average proﬁles from
the two brain samples) than for the hmeDIP counterpart
(130 560 peaks in brain; Supplementary Figure S4) while
far fewer peaks were identiﬁed following JBP enrichment
(22 561 brain peaks). The mapping of these peaks to one
of ﬁve unique regions genome was carried out to test
whether the distribution of 5hmC enrichment differed
between the techniques. In agreement with published
studies (18,26,28,29,32,33), the majority of 5hmC
enriched peak probes from the hmeDIP and hMeSeal
datasets mapped to genic loci (‘Intra-genic’, Figure 1f)
while a smaller fraction map between genes (‘Inter-
genic’, Figure 1f) or to regions at or around promoters
(‘promoter distal’; TSS +2kb to +1kb, ‘promoter
proximal’: TSS+1kb to +100 bp and ‘promoter core’;
TSS±100 bp, Figure 1f). In contrast, the JBP-1 enriched
peaks mapped largely to inter-genic loci (Figure 1f).
Between the hmeDIP and hMeSeal peak sets, there was
a notable difference in the enrichment of 5hmC peaks over
the promoter proximal regions (liver: +1.03%, brain:
+0.8% total probe enrichment in hMeSeal versus
hmeDIP datasets) in the libraries puriﬁed by hMeSeal.
Taken together, both hmeDIP and hMeSeal based tech-
niques are ultimately capable of reporting similar
hydroxymethylome patterns.
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Antibody-based enrichment of 5hmC DNA reveals a slight
CpG sequence bias
As previous studies have reported a CpG bias associated
with the antibody-based puriﬁcation techniques (31), we
set out to test this within our dataset in comparison to the
hMeSeal protocol. For both brain and liver samples, we
observe a shift in the number CpGs found across enriched
DNA fragments between the two techniques (Supple-
mentary Figure S5). This difference is most clearly
observed in the 5hmC rich brain samples in comparison
with the liver, which contains lower 5hmC levels globally.
Consistent with previous reports, we ﬁnd that in both
tissues the antibody-based puriﬁcation method enriches
for fragments of DNA containing higher densities of
CpG dinucleotides than the hMeSeal technique (mean
CpG observed/expected 0.284 and 0.228 for brain and
liver hmeDIP respectively, 0.22 and 0.198 for brain and
liver hMeSeal; Supplementary Figure S5). As such, the
hMeSeal technique may be important in the study of
5hmC over regions of low CpG composition, whereas
the antibody may be better suited to the study of
hydroxymethylation at CpG islands and promoters with
more intermediate levels of CpG density (ICPs). Extension
of our analysis to investigate the number of 5hmC marked
peak probes aligning to annotated CpG islands in our
datasets reﬂects this. CpG islands are typically devoid of
any form of cytosine modiﬁcation and we ﬁnd that ultim-
ately all three afﬁnity-based techniques are unable to
purify such loci, with the total number of peak probes
mapping to a CpG island <0.11% of total probes in
either tissue by either technique (Figure 1g). There is
however a larger proportion of promoter CGIs marked
by 5hmC following JBP-based afﬁnity enrichment;
however, when taken together with the earlier observa-
tions (Figure 1c, d and f and Supplementary Figure S3),
this is likely to be not signiﬁcant due to background noise.
Analysis of genic 5hmC patterns between hmeDIP and
hMeSeal generated datasets
As the majority of 5hmC enriched DNA is found within
genic regions, we next focused our analysis on these
regions. Plots of the average 5hmC patterns across all
genes ±25% of their length present on the high-density
tiled microarrays (n=6777) reveal highly similar
promoter and genic 5hmC patterns in both liver and
brain (Figure 2a) following both hmeDIP and hMeSeal
enrichment. Typically, this presents itself as a dramatic
loss of 5hmC directly over the TSS with an elevated
gene body 5hmC content which dips down again over
the 30-end. Although both hmeDIP and hMeSeal brain
and liver datasets exhibit a clear drop off in the 5hmC
signal directly around the TSS, levels of 5hmC are
heightened over promoter proximal regions following
chemical capture-based enrichment (which agree with
our earlier observations regarding the distributions of
peak probes, Figure 1f). In stark contrast, JBP1 enriched
patterns are the direct opposite of those seen when
enriched by hmeDIP or hMeSeal approaches, with a
peak of 5hmC observed directly over the TSS
(Supplementary Figure S6)—a result which is not
supported by the ﬁeld at present. Focussing on the
hmeDIP and hMeSeal datasets, further analysis reveals
that the average levels of 5hmC in each gene are highly
correlated when comparing the two techniques (cor
values of 0.918 and 0.872 for brain and liver respectively,
Figure 2b, i and ii) while the levels of correlation are con-
sistent between the two techniques when comparing values
between the tissues (cor values of 0.611 and 0.671 for
hMeSeal and hmeDIP, respectively, Figure 2b, iii and
vi). Taken together, both techniques appear to be
capable of ultimately generating similar 5hmC enriched
datasets. Although the use of both techniques results in
the generation of largely similar genome wide 5hmC
patterns, we found that a small group of genes which
were reproducibly differentially enriched in both biolo-
gical replicates depending on the technique used to
purify the fragments (brain=203, liver=44); Supple-
mentary Figure S7a). Subsequent analysis revealed that
many of the hmeDIP enriched genes contain lower levels
of 5hmC than is found across the rest of the genome
(antibody enriched/hMeSeal depleted genes: mean log2
0.43 by hmeDIP, mean antibody 5hmC levels across
genome: log2+0.014 by hmeDIP) and that this elevation
in the antibody enriched datasets relative to the chemical
capture sets was in fact due to the lower values reported by
hMeSeal over genuinely 5hmC-depleted loci (Figure 2c
and Supplementary Figure S7b). Indeed, genome
browser visualization of many of these hmeDIP enriched
genes found that they clustered to large regions of the
genome which were vastly depleted in the 5hmC modiﬁ-
cation (Supplementary Figure S7b), which would indicate
that higher levels of noise are introduced by the antibody-
based approach in such regions. In contrast, the small
number of genes with elevated genic 5hmC in the
hMeSeal dataset (brain n=30, liver n=18) appear to
be genuinely enriched over general genomic 5hmC levels
by both techniques (Figure 2c and Supplementary Figure
S7c). The functional signiﬁcance of the elevated genic
5hmC in these genes is however unknown as GO term
analysis yielded no particular set of genes with
overlapping functional pathways. Nevertheless, it
appears that the hMeSeal can enrich for 5hmC with less
noise compared with the antibody-based approach.
Both hmeDIP and hMeSeal enriched DNA fragments
associate with a speciﬁc subset of chromatin modiﬁcations
and binding proteins
Following the analysis of the genome-wide patterns of
5hmC, we set out to relate these pattern to a selection of
commonly studied histone modiﬁcations with the aim of
better understanding (i) the relationships between the
5hmC modiﬁcation and the chromatin landscape and (ii)
differences in these relationships between enrichment
strategies. To do so, we analysed publically available
ENCODE (‘ENCODE/LICR histone modiﬁcation’
tracks) genome-wide sequencing datasets generated by
the Ren lab at the University of California, San Diego,
for both mouse brain and liver tissue samples. In short,
ﬁve histone modiﬁcations were selected: H3K4me3 (found
at active promoters), H3K27me3 (found at bivalently
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marked promoters and transcriptionally silent gene
bodies), H3K4me1 (found over poised enhancers as well
as some promoters), H3K27ac (found over active pro-
moters as well as active enhancers when marked by
H3K4me1) and H3K36me3 (found over actively
transcribing gene bodies). In addition to these histone
modiﬁcations, we also investigated the relationships
between 5hmC presence and the binding of CTCF (an
insulator protein) and RNA polymerase II (indicative of
active promoters). To study the overlap between the
sequencing datasets, data were ﬁrst restricted to the
regions covered on the microarray and resulting Encode
deﬁned peaks compared for an overlap with 5hmC peaks.
Co-localization of peaks was deﬁned as overlapping peaks
mapping to regions of single histone modiﬁcation (i.e.
regions containing only H3K4me3 and not H3K4me3
and H3K27me3) displayed as a percentage of the total
number histone modiﬁcation peaks (Figure 3a and
Supplementary Figure S8a). In agreement with the
general 5hmC patterns observed over genes (Figure 2a),
modiﬁcation patterns that are typically found over
promoter regions (H3K4me3+, H3K27ac+ & RNAP
II+) were depleted in their relation to the 5hmC mark
by following both hmeDIP and hMeSeal enrichment,
but not JBP afﬁnity puriﬁcation which instead exhibited
moderate enrichment (Figure 3a–c and Supplementary
Figure S8a). No discernible relationship was observed
between the 5hmC modiﬁcation and regions rich in the
H3K27me3 mark following any method of 5hmC enrich-
ment—which agrees with the notion that the 5hmC modi-
ﬁcation is largely euchromatic (17,28–30,32). In contrast,
both the hmeDIP and hMeSeal enriched datasets were
found over a large number of H3K36me3+ve peaks
(36% and 53.4% of total H3K36me3 peaks in the brain
and 39% and 64% total H3K36me3 peaks in the liver for
hmeDIP and hMeSeal, respectively; Figure 3a and c and
Supplementary Figure S8a) which relates to the well-cited
relationship with actively transcribing genes as well as
the global distribution of the 5hmC marks outlined in
Figure 1f. 5hmC has been previously shown to be
enriched at enhancer elements which may in turn be func-
tionally important for the expression of nearby genes
(13,41–44). Accordingly, we observe high levels of
overlap between peaks of 5hmC at predicted active enhan-
cers marked by H3K4me1+/H3K27ac+(28% and 32% of
total active enhancers in the brain and 43% and 46% in
the liver for hmeDIP and hMeSeal, respectively) as well as
poised enhancers marked by H3K4me1+/H3K27ac
(54% and 57% of total poised enhancers in the brain
and 62% and 84% in the liver for hmeDIP and
hMeSeal, respectively; Figure 3a–c and Supplementary
Figure S8a). Once more JBP-based afﬁnity derived
patterns of 5hmC do not show similar relationships with
the H3K36me3, H3K4me1 and H3K27ac marks. Finally,
Figure 2. Genic patterns of 5hmC enrichment are similar following enrichment by hmeDIP or hMeSeal. (a) Average pattern of 5hmC across
promoter and genic regions are highly similar following independent puriﬁcation by either hmeDIP (purple) or hMeSeal (blue) in both the brain
(i) and liver (ii). Average 5hmC values were calculated at positions relative to the full length of the gene with analysis extending 25% up and
downstream. Y-axis plots average log2 scores taken from microarray datasets. (b) Scatter plots of average length adjusted genic levels of 5hmC
between hmeDIP and hMeSeal in the brain (i) and liver (ii) tissues (each n=2). Scatterplots are also shown to compare the relationships between the
genic 5hmC levels across tissues by both hMeSeal (iii) and hmeDIP (iv). Pearson correlation values are shown in red in each plot. Data are plotted
for average log2 scores from 2 to+2 for the 5hmC content of each gene following length adjustment. (c) Box plots of average length normalized
5hmC levels across genes exhibiting a strong relative enrichment following either antibody (i) or chemical capture (ii) puriﬁcation compared to all
genes on the array. Antibody puriﬁed; purple, chemical capture puriﬁed; blue. Genes enriched by hmeDIP versus hMeSeal are typically depleted in
5hmC with respect to all genes indicating higher levels of noise. Conversely, regions enriched by hMeSeal are genuinely enriched over the bulk of the
genes on the array.*Denotes Willcox P-value scores <0.05.
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hmeDIP and hMeSeal (but not JBP afﬁnity) derived
5hmC peaks are seen to overlap with a proportion of
regions which are bound by the insulator protein CTCF,
which may relate 5hmC distribution to the regulation of
higher order chromatin compaction. Taken together, these
data suggest that the 5hmC fragments generated by either
hmeDIP and hMeSeal puriﬁcation (but not those from
JBP-1 afﬁnity) associate with similar distributions of
histone modiﬁcation, with a general elevation in overlap
seen following hMeSeal-based methods (i.e. increased
H3K36me3+, enhancer element and CTCF occupancy
in the chemical capture-based 5hmC dataset relative to
antibody-based datasets; Figure 3 and Supplementary
Figure S8).
Regions of differential enrichment between hmeDIP and
hMeSeal reveal an antibody bias towards simple tandem
repeats
Although the general 5hmC patterns generated following
antibody or hMeSeal-based puriﬁcation (Figures 1c, e and
f and 2a), a small number of regions were found to contain
high levels of high variance between the two datasets. To
analyse these regions, we selected probes residing in large
regions (>200 bp) containing high levels of change in
either the antibody generated dataset or the chemical
capture dataset (Figure 4a, see ‘Materials and Methods’
section). It is important to note that these peak sets rep-
resent a very low proportion of the total probe count
(brain; 6674 probes or 0.3% of total, liver; 5529
probes or 0.25% of total) once more indicating how re-
producible the majority of the data is between the two
techniques. Nevertheless, these regions are consistently
variable between the techniques in both biological repli-
cates, containing >1.5 fold (log2) change between the cor-
responding probe values in each dataset over a window
covering at least three probes. Relative to hMeSeal, the
hmeDIP libraries contained a greater number of differen-
tially enriched probe regions—which is likely to represent
the higher levels of background noise in these datasets
(Figure 4a).These variable regions differed in their genic
distribution from that of the majority of enriched probes
(Figures 1f and 4b); mapping largely to non-genic regions
(‘intra-genic’; Figure 4b). In agreement with earlier results
(Figures 1f and 2a), the chemical capture-based enrich-
ment dataset was also found to contain a greater propor-
tion of speciﬁc peaks at regions directly upstream of the
TSS (‘promoter proximal’; Figure 4b).
Previous work has indicated that antibody methods of
5hmC enrichment are biased towards CA simple repeats in
mouse ES cell data (31). Therefore, we set out to test
whether or not the regions of high variance between the
two techniques occurred over any particular class of
Figure 3. Regions of 5hmC enrichment are associated with select histone modiﬁcations. (a) Overlap between peaks of histone modiﬁcations/DNA
binding proteins with peaks of 5hmC derived through the three puriﬁcation techniques in the mouse brain. Plots show percentage of total histone
modiﬁcation peaks which overlap with a peak of 5hmC by at least 1 bp. Total number of histone modiﬁcation peaks are shown below in square
brackets. (b) Average 5hmC proﬁles over 10 kb windows at ‘poised’ and active enhancers compared with active promoters in the brain for each
enrichment technique. (c) Genome browser visualization of 5hmC patterns (hmeDIP: purple, hMeSeal: teal, JBP-1 afﬁnity: orange) overlap with
select histone modiﬁcations (H3K4me1:light blue, H3K4me3: dark blue, H3K27me3: red, H3K27ac: green, H3K36me3: pink) in the mouse brain.
Array data plotted on log2 scale while ChIP-seq the number of reads. Refseq genes are displayed below.
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repetitive sequences. Analysis of the average 5hmC levels
in the probes associated with a speciﬁc family of repetitive
elements and simple tandem repeats reveals that hmeDIP
approaches enrich for 5hmC over several subclasses of
repeat, mainly those belonging to Line1 elements and
simple repeats (all Willcox P-values <0.05, Figure 4c).
In contrast, the levels of 5hmC present at the Line1
elements and simple repeats following hMeSeal enrich-
ment are signiﬁcantly lower (all Willcox P-values <0.05,
Figure 4c). In all cases (with the exception of the TC
simple repeats), the levels of 5hmC at these loci are
lower than that observed for genic probes (Supplementary
Figure S9) indicating that although enriched by the
antibody, these repetitive elements have lower levels of
5hmC compared to gene bodies.
Following this result, we ﬁnd that many of the strongest
regions of variance showing antibody-speciﬁc enrichment
are indeed found to correspond not only to simple tandem
repeats but to a whole spectrum of simple repeats of
varying length (Figure 4d, ii and iii). However, regions
Figure 4. A small number of loci show high levels of technique speciﬁc enrichment bias. (a) Plot of the total number of probes on the microarrays
which exhibit >log2 1.5-fold differences in 5hmC levels across both brain and liver tissues following either hmeDIP (purple) or hMeSeal (blue). (b)
Genomic distributions of the differential probes shown in Figure (a) in both brain (i) and liver (ii) mapped to the same regions outlined in Figure 1e.
Values are shown as percentages of all probes (%). Red lines highlight the relative changes in the genomic distribution. (c) Box plots of average
5hmC levels (log2 values) across a host of repetitive elements and simple tandem repeats reveal some antibody speciﬁc bias. 5hmC levels in datasets
generated by hmeDIP (purple) or hMeSeal (blue) are plotted both for brain (Br) and liver (Liv). hmeDIP bias is seen at line1 elements as well as at
CA and TC simple repeats.*Denotes Willcox P-value scores <0.05. (d) Examples of strong regions of technique speciﬁc enrichment bias. Microarray
patterns of 5hmC enriched by hmeDIP (purple) and hMeSeal (blue) are shown on log2 scales from+2.5 to 2.5. Regions of depletion are marked as
grey bars for each technique. Genomic coordinates are given above for mouse mm9 build. Relative changes in the 5hmC signal between the two
techniques are also displayed with green bars indicating hmeDIP bias and red bars hMeSeal bias. Gene structures are given below with directionality
denoted by arrows. Regions rich in simple repeats are displayed as solid black bars. Scale bars are shown above for reference. Boxed areas represent
regions validated independently by gRES-qPCR. Boxed bar plots represent the percentage of each modiﬁcation at a single CpG in the sequence
CCGG following normalization (purple; 5hmC, red; 5mC, green; C). Error bars display the standard error of the biological replicates.
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of hMeSeal elevation cannot be explained in such a way
but may simply represent clearer enrichments than the
antibody (Figure 3d, iv and v and Supplementary Figure
S7c). To test which of the two techniques was reporting on
the true 5hmC patterns over these loci, we carried out
gRES-qPCR at variable regions containing a single
MspI sites. As this technique is independent of the puriﬁ-
cation steps required for hmeDIP and hMeSeal, it
provided useful validation of the levels of modiﬁcation
present over a single CpG site at a speciﬁc locus.
Accordingly, a 5hmC negative control region within
the Gapdh promoter CpG island shows low levels of
modiﬁcation present at this site following gRES-qPCR
(Figure 4d, i). The loci containing hmeDIP elevated
5hmC signals at regions containing simple repeats were
found in fact to contain low levels of 5hmC by gRES-
qPCR (Muc6: 3.13% & Mill1: 2.51% of CpGs are found
to be marked by 5hmC; Figure 4d, ii and iii) indicating
that these enrichments are likely an artefact of the
antibody puriﬁcation technique. Interestingly regions of
hMeSeal elevated signal were seen to be genuinely
enriched in the mark (Nanos2: 19.8% & Tfdp1: 18.1% of
CpGs are found to be marked by 5hmC; Figure 4d, iv and
v). Although CT(n) simple repeats have previously been
observed to be enriched in the antibody-based technique
and absent in the chemical capture (31), here we show that
the nature of the repeat-based bias associated with the
5hmC antibody is far greater than previously noted.
The Imprinted loci at Tsix/Xist and H19/Igf2r reveal
striking regions of technique dependent 5hmC variance
In the course of our global analysis, we found that two of
the most widely studied imprinted loci, H19/Igfr2 and
Tsix/Xist were also highly variable in their 5hmC
patterns in a technique dependant manner (Figure 5).
The epigenetic landscape at imprinted loci is thought to
be particularly important for the maintenance of particu-
lar expression states and it is therefore crucial that quan-
titative DNA modiﬁcation levels can be measured. Not
only do the 5hmC patterns differ in the datasets
reported here, but these same regions also differ when
we analyse previously published datasets from a study
investigating the changes to mouse liver 5hmC following
exposure to the non-genotoxic carcinogen, phenobarbital
(25) (Supplementary Figure S10). For the Tsix/Xist locus,
these differences can be attributed to the aforementioned
alignment with regions of simple repeats (Figure 5b).
Although the large region of hmeDIP speciﬁc 5hmC en-
richment between the H19 and Igf2r genes did not align to
many simple repeats, there is an enrichment of TC simple
repeats towards the 30-end of the locus (Figure 5a, simple
repeats; red box) (Supplementary Figure S11). gRES-
qPCR at these loci reveals that hMeSeal enrichment
appears to best represent the true hydroxymethylome
over these repetitive regions (Figure 5). Interestingly,
the strong region of hmeDIP speciﬁc enrichment at the
H19/Igf2r locus is also seen to be strongly enriched for
the 5mC modiﬁcation following immunoprecipitation
with antibodies speciﬁc for the 5mC mark (methyl-DNA
immunoprecipitation; MeDIP, Supplementary Figure
S12), which can be independently validated as 5mC
enriched by gRES-qPCR (between 37–49% and 46–62%
5mC at four MspI sites at these loci in brain and liver,
respectively; Figure 5). As dot blot analysis has previously
shown that the 5hmC antibody harbours no speciﬁcity
towards 5mC modiﬁed DNA sequences, and vice versa
(26), it is unlikely that the 5hmC antibody is cross
reacting to the 5mC mark. Therefore, this region may
exhibit a strong 5hmC signal following hmeDIP enrich-
ment due to the high levels of repetitive sequence at this
locus.
DISCUSSION
Since its ‘re-discovery’ in 2009, research involving
5-hydroxymethylated DNA has increased at an incredible
rate (for a review see (6)). The ﬁeld has been driven by a
marked increase in the number of potential tools for
analysing the mark, each with its particular set of advan-
tages and disadvantages (for a recent review see (5)). With
our knowledge of the 5hmC modiﬁcation expanding
rapidly, comparison of 5hmC enrichment techniques is
timely. In this study, we compared three widely used af-
ﬁnity-based techniques for 5hmC puriﬁcation (antibody-
based, chemical capture-based and JBP-1 afﬁnity-based
techniques) across mouse tissues containing either high
(whole brain) or moderate (liver) levels of the modiﬁca-
tion. Generally, it was noted that both the antibody
(hmeDIP) and chemical capture (hMeSeal)-based tech-
niques were very similar in their genome-wide enrichments
of the 5hmC modiﬁcation (enriched over genic loci,
depleted over TSSs) and exhibited high levels of tissue
speciﬁcity as well as low levels of inter-individual variation
(Figure 1b–d). In contrast, the 5hmC patterns generated
through afﬁnity-based enrichment with the trypanosome
JBP-1 protein differed signiﬁcantly (Figure 1b–d and
Supplementary Figures S2, S3 and S6). In agreement
with previous reports, there was a slight bias towards
CpG-rich regions of the genome in the hmeDIP-based
technique (31) (Supplementary Figures S5); however,
these differences did not extend to CpG islands, which
remain largely modiﬁcation free in the tissues examined
(Figure 1g).
Analysis of the chromatin modiﬁcations which are
associated with peaks of 5hmC following enrichment by
the three afﬁnity-based puriﬁcation techniques once more
revealed the similar nature of the 5hmC landscapes
generated following hmeDIP and hMeSeal. In the
hmeDIP and hMeSeal datasets, 5hmC was seen to
overlap with regions marked by H3K36me3 (a genic
mark of active transcription) as well as both poised
(H3K4me1+/H3K27ac) and active (H3K4me1+/
H3K27ac+) enhancers and CTCF sites, a result previously
reported by others (41,45). In all cases, the hMeSeal-based
enrichment showed elevated levels of enrichments between
the DNA modiﬁcation and the histone marks which may
represent a superior method of 5hmC enrichment. 5hmC
patterns generated following JBP-1 afﬁnity-based methods
failed to relate these same chromatin states, once more
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revealing the shortcoming of using such an approach to
study the 5hmC modiﬁcation.
Although the majority of probes on the arrays were
similar in their enrichment levels following puriﬁcation
by the two techniques, a small subset (between 0.25%
and 0.31% of total probes) were found to vary by
greater than log2 1.5-fold (Figure 3a). The bulk of these
could be attributed to an increase in the overall puriﬁca-
tion levels at particular loci, which did not affect the
general distributions of 5hmC enriched by the two
methods (Figure 3d and Supplementary Figures S5 and
S6), while a subset were dramatically enriched only in
the antibody-based method. It was noted that many of
these regions were overlapping or adjacent to genomic
regions containing simple repeats and tandem repeats
(Figure 3d). Additionally, large regions of hmeDIP
speciﬁc enrichment were noted over the well-studied im-
printed loci of H19/Igf2r and Tsix/Xist (Figure 4).
Independent validation by glucosylation-mediated restric-
tion enzyme sensitive qPCR (‘gRES-qPCR’) found little
or no 5hmC modiﬁed CpG dinucleotides at these loci,
which was in agreement with the hMeSeal-based
datasets arguing that antibody-based enrichment tech-
niques may harbor some bias over repetitive regions of
the genome.
In conclusion, we ﬁnd that both the antibody (hmeDIP)
and chemical capture (hMeSeal)-based techniques, but
not JBP-1 afﬁnity-based methods, are accurate at repro-
ducibly detecting genome-wide patterns of 5hmC across
tissues containing both higher (whole brain) and lower
(liver) levels of total 5hmC. Although the reasons for the
relative failure of JBP-1-based afﬁnity enrichment are
unclear, several predictions can be made. The most
likely is that the enrichment is working albeit at a low
level as evidenced by the high cycle threshold values
during qPCR compared to hmeDIP and hMeSeal.
Alternatively, the JBP-1 protein may also exhibit bias to
certain portions of the genome; primarily as the JBP-1
puriﬁed libraries were found to be enriched directly over
the TSS, a result which differs signiﬁcantly from our own
hmeDIP and hMeSeal datasets as well as the many
published hydroxymethylome patterns. Nevertheless, the
complementarity of the hmeDIP and hMeSeal-based tech-
niques provides researchers with independent methods of
5hmC enrichment and validation which is applicable to
both genome-wide and locus-speciﬁc studies (25). While
the reduced background noise and higher afﬁnity
towards particular chromatin states observed with
chemical capture-based methods makes this a highly at-
tractive approach for the analysis of genome-wide 5hmC
Figure 5. Imprinted loci at the H19/Igf2r (a) and Tsix/Xist (b) genes contain strong regions of technique dependant enrichment bias. Microarray
data is plotted as describe earlier for Figure 3d. Enrichment by hmeDIP=purple track, hMeSeal= blue track, regions of depletion=grey in both
tracks, hmeDIP bias=green track, hMeSeal bias= red track. Genes are displayed below as blue bars and simple repeats as black bars. The simple
repeat highlighted in red refers to a region of TC tandem repeats. Boxed areas represent regions validated independently by gRES-qPCR (see
description in Figure 4d).
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patterns (Figure 1d), antibody-based methods typically
result in a greater total return of enriched DNA (as
indicated by higher cycle threshold values generated
during qPCR, Supplementary Figure S1) which may be
more suitable for attaining enough material for down-
stream analysis. Ultimately, both techniques are suitable
for the interrogation of 5hmC patterns at the non-repeti-
tive regions of the genome. One major drawback of all of
these techniques is that the enriched DNA fragments are
all relatively large in size (sonication shearing of DNA
typically results in fragments 150 bp–1 kb). As such it is
hard to accurately determine the modiﬁcation status of a
single CpG when starting with DNA fragments of this
length. In future, it is possible that these three methods
of 5hmC enrichment may be superseded by technologies
which can map 5hmC at single base pair resolution in a
cost-effective manner (33,35). Nevertheless, both hmeDIP
and hMeSeal-based enrichment methods can provide a
cost-effective and accurate representation of the 5hmC
landscape.
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